Anika Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Anika Therapeutics Inc.
- Former names
- Anika Research Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Bedford
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ANIK
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000898437
- EIN
- 04-3145961
Board of directors
-
Cheryl R. Blanchard · Director · President, CEO, DirectorSince 2023
-
Gary P. Fischetti · DirectorSince 2023
-
Glenn R. Larsen · DirectorSince 2023
-
Jeffery S. Thompson · DirectorSince 2023
-
John B. Henneman III · DirectorSince 2023
-
Joseph H. Capper · DirectorSince 2024
-
Sheryl L. Conley · DirectorSince 2023
-
Stephen D. Griffin · Director · President and CEOSince 2026
-
Stephen Richard · DirectorSince 2023
-
Susan L. N. Vogt · DirectorSince 2023
-
William R. Jellison · DirectorSince 2024
Chief executives
Cheryl R. Blanchard
· President, CEO, Director
Dates unknown
Stephen D. Griffin
· President and CEO
Dates unknown
Director election results
Annual meeting of June 18, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
94.3%
-
98.7%
-
99.4%
Board connections
5 of this board's directors also sit on 9 other boards.
- via Joseph H. Capper and Sheryl L. Conley
- via John B. Henneman III
- via William R. Jellison
- via Cheryl R. Blanchard
- via William R. Jellison
- via John B. Henneman III
- via Joseph H. Capper
- via William R. Jellison
- via Cheryl R. Blanchard
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $264,298
- 4 purchases by 3 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 4, 2026 | Gary P. Fischetti Director | Open-market purchase | +1,000 | $20.32 | $20,315 |
| Aug 3, 2026 | Gary P. Fischetti Director | Open-market purchase | +1,000 | $20.75 | $20,745 |
| Jun 18, 2026 | Gary P. Fischetti Director | Grant or award | +10,402 | — | — |
| Jun 18, 2026 | John B. Henneman III Director | Grant or award | +10,402 | — | — |
| Jun 18, 2026 | Stephen Richard Director | Grant or award | +10,402 | — | — |
| Jun 18, 2026 | Joseph H. Capper Director | Grant or award | +10,402 | — | — |
| Jun 18, 2026 | Sheryl L. Conley Director | Grant or award | +10,402 | — | — |
| Jun 3, 2026 | Stephen D. Griffin Director, Officer (President and CEO) | Option exercise | +12,840 | — | — |
| Jun 3, 2026 | Stephen D. Griffin Director, Officer (President and CEO) | Shares withheld for tax | −3,769 | $14.41 | $54,311 |
| May 1, 2026 | John B. Henneman III Director | Open-market purchase | +5,000 | $14.66 | $73,300 |
| Apr 30, 2026 | Stephen D. Griffin Director, Officer (President and CEO) | Open-market purchase | +12,200 | $12.29 | $149,938 |
| Mar 15, 2026 | Colleran David Officer (EVP, General Counsel, Corp Sec) | Option exercise | +6,449 | — | — |
| Mar 15, 2026 | Cheryl R. Blanchard Director | Option exercise | +25,131 | — | — |
| Mar 15, 2026 | McLeod Ian Officer (SVP, CAO & Treasurer) | Option exercise | +2,658 | — | — |
| Mar 15, 2026 | Colleran David Officer (EVP, General Counsel, Corp Sec) | Shares withheld for tax | −1,893 | $14.20 | $26,881 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.